NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Start Multiple Choice Practice Test
Start Flash Cards

Practice this question and more.

Which of the following is not recommended for nosocomial MRSA treatment?

  1. Linezolid

  2. Mupirocin

  3. Daptomycin

  4. Vancomycin

The correct answer is: Mupirocin

While all of these options have shown some effectiveness in treating nosocomial MRSA (a strain of staph bacteria resistant to many antibiotics), mupirocin is typically used for prevention or treatment of skin infections, and is not recommended as a first-line treatment for nosocomial MRSA. Other options such as linezolid, daptomycin, and vancomycin have been specifically approved for this type of infection and have shown better results in eradicating the bacteria. It is important to consult with a healthcare professional for the most appropriate treatment for MRSA, as treatment may vary depending on the individual's medical history and the severity of the infection.

More Questions Like This